Business Insider reported:

Pfizer and Moderna raised the prices on their coronavirus shots in their latest contract negotiations with the European Union, the Financial Times reported.

One official close to the negotiations told the FT that Pfizer and Moderna had used the “usual pharma rhetoric” to increase the price. The companies essentially said that “vaccines work so they increased the ‘value,’” the source said.

Similar Posts

Leave a Reply

Your email address will not be published.